Frontlight ResearchEarly access
Trial site
Liaoning Cancer Hospital
- 3running trials
The trials here
What the 3 trials at this site are about, from their registry records.
- Conditions
- Metastatic breast cancer1 trial
- Thyroid cancer1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 32 trials
- Phase 21 trial
- Status
- Enrolling by invitation1 trial
- Not yet recruiting1 trial
- Recruiting1 trial
- Lead sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.1 trial
- Huabo Biopharm Co., Ltd.1 trial
- Jiangsu Alphamab Biopharmaceuticals Co., Ltd1 trial
Running trials
Enrolling by invitation
A Study of HB0025 Plus Nab-paclitaxel as First Line Therapy for TNBC
Recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Metastatic breast cancer1 recruiting
- Thyroid cancer1 recruiting
- Triple-negative breast cancer1 recruiting
Site data: ClinicalTrials.govUpdated 12 Nov 2026